Vyome Holdings HIND
NASDAQ HIND
$2.25 -0.03 (-1.32%)
As of: Aug 21, 2026 · 3:38 PM EDT

Vyome Holdings (HIND) Other Accumulated Expenses (2015 - 2026)

Vyome Holdings (HIND) posted quarterly Other Accumulated Expenses of $227766.0 for Q1 2026, up 384.61% year-over-year from $47000.0 in Q1 2025, and down 7.02% quarter-over-quarter from $244974.0 in Q4 2025.

Vyome Holdings (HIND) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

Vyome Holdings' Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $227766.0 for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 384.61% year-over-year to $227766.0; the TTM figure through Mar 2026 stood at $227766.0 (up 384.61% YoY), while the FY2025 annual figure was $244974.0, up 126.96% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $227766.0, down from $244974.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $491000.0 in Q4 2022, with the low at $45000.0 in Q3 2024.
  • The 5-year median for Other Accumulated Expenses is $105000.0 (2023), against an average of $155993.0.
  • The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses sank 88.19% in 2023, then jumped 384.61% in 2026.
  • Vyome Holdings' Other Accumulated Expenses stood at $491000.0 in 2022, then tumbled by 88.19% to $58000.0 in 2023, then surged by 86.1% to $107937.0 in 2024, then jumped by 126.96% to $244974.0 in 2025, then fell by 7.02% to $227766.0 in 2026.
  • Business Quant data shows HIND's Other Accumulated Expenses at $227766.0 in Q1 2026, $244974.0 in Q4 2025, and $93204.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Vyome Holdings 16.07 Mn 8.18 Mn 11,658.00

Historic Data

Download Data
DateValue
Jun 30, 2026 107,660.00
Mar 31, 2026 227,766.00
Dec 31, 2025 244,974.00
Sep 30, 2025 93,204.00
Jun 30, 2025 54,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 107,937.00
Sep 30, 2024 45,000.00
Jun 30, 2024 47,000.00
Mar 31, 2024 56,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 105,000.00
Jun 30, 2023 94,000.00
Mar 31, 2023 345,000.00
Dec 31, 2022 491,000.00
Sep 30, 2022 115,000.00
Jun 30, 2022 222,000.00
Mar 31, 2022 299,000.00
Dec 31, 2021 185,000.00
Sep 30, 2021 359,000.00